The National Institutes of Health (NIH) has awarded M. Dennis Leo, PhD, assistant professor in the Department of Physiology at the University of Tennessee Health Science Center (UTHSC), a $1.9 million grant for his project titled “Chloride Channels in Diabetic Vascular Disease.” The study will investigate cellular signaling pathways damaged by diabetes and how they… Read More
The Department of Defense (DOD) has awarded a $1.3 million grant to researchers at the University of Tennessee Health Science Center, Memphis Veterans Affairs (VA) Medical Center, and Virginia Commonwealth University (VCU) to assist caregivers of veterans who are living with traumatic brain injury (TBI) and dementia. Linda Nichols, PhD, FGSA, FSfAA, professor in the… Read More
For the second year in a row, Paul Klimo, Jr. MD, MPH, associate professor in the Department of Neurosurgery at the University of Tennessee Health Science Center, was awarded the Pediatrics Paper of the Year by the Congress of Neurological Surgeons (CNS) during the CNS annual meeting in San Francisco, California. The paper, “The Preventable Shunt… Read More
Steven Goodman, PhD, vice chancellor for Research at the University of Tennessee Health Science Center, announced that UTHSC has achieved record growth in research funding. Recently released numbers from the Office of Research show research grants and contract awards for FY19 totaling more than $100 million for the first time in UTHSC history. This number… Read More
UTHSC’s Tennessee Clinical and Translational Science Institute (TN-CTSI) held a ribbon cutting and grand opening celebration last week for its new offices on the second floor at 66 North Pauline. TN-CTSI was established in 2018 to address the health inequalities in the state of Tennessee. Its mission is to stimulate the discovery and translation of… Read More
Duane Miller, PhD, retired from the College of Pharmacy at the University of Tennessee Health Science Center in 2015, but he still comes to work four days a week. Dr. Miller has made research his retirement, because how can you sit at home when you’ve spent your life ferreting out what could lead to next-generation… Read More
Patients with sickle cell disease will soon have a new treatment option to reduce pain crises caused by obstructed blood flow. The FDA has approved use of the drug crizanlizumab based on the results of a clinical trial led by Kenneth Ataga, MD, Plough Foundation Endowed Chair in Sickle Cell Disease and director of the… Read More
A new study by researchers at the University of Tennessee Health Science Center and the University of Iowa provides good news for patients with atrial fibrillation (AFib), or irregular heartbeat, who are at greater risk for stroke but cannot tolerate long-term anticoagulation therapy, the first-line treatment to prevent stroke. The study determined that an implanted… Read More
